myPHteam

According to the knowledge base, Tyvaso (Treprostinil) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease. It is taken four times a day by inhalation Show Full Answer

According to the knowledge base, Tyvaso (Treprostinil) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease. It is taken four times a day by inhalation using a specialized Tyvaso inhalation system.

One member of myPHteam mentioned, “I take Tyvaso and it has helped!”

For more detailed information, you can visit the Tyvaso website: [Tyvaso — United Therapeutics](https://www.tyvaso.com/dtc).

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Tyvaso (Treprostinil) for Pulmonary Hypertension | myPHteam

New Pulmonary Arterial Hypertension Medications: 4 Advances in Treatment | myPHteam